D-dopa is unidirectionally converted to L-dopa by D-amino acid oxidase, followed by dopa transaminase

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 11, 2006, Pages 1042-1046

  Wu, Mei ^a   Zhou, Xiang Jun ^a   Konno, Ryuichi ^b   Wang, Yong Xiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chiral inversion; D amino acid oxidase; D dopa; Dopa transaminase; HPLC; L dopa

Indexed keywords

2 OXOACID; AMINOTRANSFERASE; AMINOTRANSFERASE INHIBITOR; BENZOIC ACID; CARBIDOPA; DEXTRO AMINO ACID OXIDASE; DOPA; DOPA TRANSAMINASE; LEVODOPA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHIRALITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENANTIOMER; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY HOMOGENATE; MEASUREMENT; MOUSE MUTANT; NONHUMAN; RAT; SEPARATION TECHNIQUE; TRANSAMINATION;

ANIMALS; CARBIDOPA; D-AMINO-ACID OXIDASE; DIHYDROXYPHENYLALANINE; ENZYME INHIBITORS; KIDNEY; LEVODOPA; MICE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM BENZOATE;

EID: 33750075441     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04484.x     Document Type: Article

References (25)

1. Moore KE, Goodale DB. 6-Hydroxydopamine-induced dopaminergic receptor supersensitivity: Studies with D-and L-dopa. In: Jonsson G, Malmfors T, Sachs C (eds). Chemical Tools in Catecholamine Research. I. North-Holland, Amsterdam. 1975; 343-7.
2. Karoum F, Freed WJ, Chuang LW, Cannon-Spoor E, Wyatt RJ, Costa E. D-Dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats. Brain Res. 1988; 440: 190-4.
3. Moses J, Siddiqui A, Silverman PB. Sodium benzoate differentially blocks circling induced by D- and L-dopa in the hemi-parkinsonian rat. Neurosci. Lett. 1996; 218: 145-8.
4. Brannan T, Prikhojan A, Yahr MD. Elevated striatal dopamine levels following administration of D-dopa and its α-keto acid metabolite DHPPA: Behavioral and physiological studies in vivo in the rat. Brain Res. 1996; 718: 165-8.
5. Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K. Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplant. 1997; 6: 309-15.
6. Shindo H, Maeda T. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). VI. Metabolism of D-dopa in rat kidney. Chem. Pharm. Bull. 1974; 22: 1721-31.
7. Wang Q, Cwik M, Wright CJ, Cunningham F, Pelligrino DA. The in vivo unidirectional inversion of nitro-D-arginine to nitro-L-arginine. J. Pharmacol. Exp. Ther. 1999; 288: 270-3.
8. G-nitro-D-arginine. J. Pharmacol. Exp. Ther. 2005; 312: 1090-6.
9. Hasegawa H, Matsukawa T, Shinohara Y, Konno R, Hashimoto T. Role of renal D-amino-acid oxidase in pharmacokinetics of D-leucine. Am. J. Physiol. Endocrinol. Metab. 2004; 287: E160-5.
10. Hashimoto A. Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res. 2002; 955: 214-20.
11. Hashimoto A, Chiba Y. Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat. Eur. J. Pharmacol. 2004; 495: 153-8.
12. Arnold G, Liscum L, Holtzman E. Ultrastructural localizationof D-amino acid oxidase in microperoxisomes of the rat nervous system. J. Histochem. Cytochem. 1979; 27: 735-45.
13. Sasaki M, Konno R, Nishio M, Niwa A, Yasumura Y, Enami J. A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. Biochim. Biophys. Acta 1992; 1139: 315-18.
14. Waterhouse MJ, Chia YC, Lees GJ. Inhibition of human and rat hepatic transaminase activity with L-3,4-dihydroxyphenylalanine by inhibitors of peripheral aromatic amino acid decarboxylase. Mol. Pharmacol. 1978; 15: 108-14.
15. Nagasaki T, Sugita M, Fukawa H. Studies on DOPA transaminase of Alcaligenes faecalis. Agric. Biol. Chem. 1973; 37: 1701-6.
16. Nagasaki T, Sugita M, Fukawa H, Lin HT. DOPA production with Enterobacter cloacae NB 320 by transaminase reaction. Agric. Biol. Chem. 1975; 39: 363-9.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
18. D'Aniello A, D'Onofrio G, Pischetola M et al. Biological role of D-amino acid oxidase and D-aspartate oxidase. J. Biol. Chem. 1993; 268: 26 941-9.
19. Husain S, Sekar R, Rao RN. Enantiomeric separation and determination of antiparkinsonian drugs by reversed-phase ligand-exchange high-performance liquid chromatography. J. Chromatogr. A 1994; 687: 351-5.
20. Boomsma F, van den Meiracker A, Veld A, Schalekamp M. Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease. Life Sci. 1995; 57: 1753-9.
21. Konno R. D-Amino-acid oxidase and its physiological function. Int. J. Biochem. 1992; 24: 519-24.
22. Williams RE, Lock EA. Sodium benzoate attenuates D-serine nephrotoxicity in the rat. Toxicology 2005; 207: 35-48.
23. Hietala P, Linden IB, Gronfors N. The effect of simultaneous administration of 3,4-dihydroxyphenylpyruvic acid and L-dopa on the bioavailability of L-dopa in rat and mouse. J. Pharm. Pharmacol. 1979; 31: 205-8.
24. Linden IB, Karlsson M, Niemi S, Penttila A. Transamination and other metabolic pathways of 3,4-dihydroxyphenylpyruvic acid in rats when simultaneously administered with L-dopa. J. Pharm. Pharmacol. 1982; 34: 719-23.
25. Fuchs SA, Berger R, Klomp LW, de Koning TJ. D-Amino acids in the central nervous system in health and disease. Mol. Genet. Metab. 2005; 85: 168-80.